Skip to main content

Table 1 Clinical manifestations and cytogenetic abnormalities of MDS patients stratified by age groups

From: Gene mutational analysis by NGS and its clinical significance in patients with myelodysplastic syndrome and acute myeloid leukemia

 Total patients (n = 93)Younger MDS patients (n = 50)Older MDS patients (n = 43)p value
Age46 (16–87 years)43 (16–59 years)69 (60–87 years)N/A
Gender males (n, %)56 (60.2%)32 (64.0%)24 (55.8%)0.421
WBC (×109/L) (mean, range)7.9 (0.3–123.9)5.3 (0.7–123.9)3.9 (0.3–11.1)0.592
Hb (g/L) (mean, range)79.1 (26.8–163.0)80.1 (26.8–163.0)77.9 (39.0–122.0)0.701
Plate (×109/L) (mean, range)75.9 (4.0–233.0)71.9 (4.0–233.0)80.4 (3.0–586.0)0.661
Blast in BM (mean, range)5.5 (0.2–18.9)4.1 (0.2–16.4)7.1 (0.4–18.9)0.007**
  1. **Statistically singnificant difference (p < 0.01) was obseved between two groups